Five of the nation’s leading pulmonary arterial hypertension (PAH) present groundbreaking data from the REVEAL Registry, a multicenter, observational research study of PAH patients, about trends in PAH patient care. Over 3,500 patients are enrolled in the US-based registry, making it the largest PAH study in the world. The research suggests that despite a range of available therapies, patients in the United States still experience significant delays in diagnosis. Panelists discuss the need for early diagnosis of PAH and more of the latest research recommendations to improve patient outcomes.
This Pulmonary Hypertension (PH) Awareness Month webinar was a partnership between the Pulmonary Hypertension Association and the American Thoracic Society in recognition of Pulmonary Hypertension Week at the ATS, November 6-12, 2011.